Oura Health Files Confidentially for IPO Signaling Potential Market Debut for Smart Ring Maker India Plans Major Overhaul of Tax Administration to Facilitate Smooth GST Rollout Yardeni Warns Fed May Need July Rate Hike to Appease Bond Vigilantes Under Incoming Chair Warsh Japans Shipbuilding Hub Turns to Foreign Workers and AI to Tackle Labor Shortage Powell Vows No Shadow Chair Role as Historic Fed Overlap Looms with Warsh European Companies Maintain China Manufacturing Despite EU DeRisking Push CAKE Q1 2026 Earnings EPS Beats Estimates by 147 Modest Stock Uptick ATA Creativity Global American Depositary Shares Q3 2024 Earnings EPS Reflects Continuing Losses Amid Speculative Stock Movement CALX Q1 2026 Earnings EPS Matches Estimates Stock Rises 211 SSM Q1 2026 Earnings Loss per Share of 059 as PreRevenue Development Continues Flowco Holdings Inc FLOC Q1 2026 Earnings Massive EPS Beat Overshadowed by Stock Decline Remitly Q1 2026 Earnings Stellar EPS Beat Fuels Optimism Revenue Details Remain Undisclosed Lionheart Holdings Warrant CUBWW Holds Steady at 017 Amid Narrow Trading Range Q32 Bio Inc QTTB Surges 81 on Heavy Volume Key Levels to Watch Ranpak Holdings PACK Posts 18 Gain Approaches Key Resistance Level Aurelion Inc AURE Slips 1 Amid Low Volume Testing Support at 236 Gogo Inc GOGO Climbs 37 as Stock Approaches Key Resistance at 471 PutinXi Talks Revive Stalled Power of Siberia 2 Pipeline as Iran Conflict Disrupts Energy Markets SP 500 Gains as Healthcare and Tech Outperform Communication Services Lags Byju Raveendran Sentenced to Jail by Singapore Court for Contempt Edtech Giants Crisis Deepens Gold Slides as Feds Waller Signals Potential Rate Hike Amid Iran Crisis CNBC Portfolio Manager Takes Profits on Stock That Rose 46 in One Week 80 Since April US April Payrolls Exceed Forecasts Yet Underlying Economy Shows Warning Signs Bahrain Minister Hails UKGulf Trade Deal as Monumental Achievement Amid Broader Economic Talks Western Union WU Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Shares Slide Neumora Therapeutics NMRA Holds Steady at 185 as Consolidation Continues